2686 completed, 535 unknown, 465 recruiting, 420 terminated. 1188 Phase 2, 994 Not applicable, 718 Phase 3, 600 Phase 1, 385 Phase 4.
Follow Anemia: new trials by email Literature Review of Anemia trials Research Report on Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sonrotoclax in Combination With Azacitidine for Previously Untreated Higher-risk Myelodysplastic Syndromes Each treatment cycle is 28-days. Azacitidine 75 mg/m² is administered subcutaneously or intravenously on Days 1-7 of each cycle. Sonrotoclax is orally administered once daily on Days 1-14 within each - MDS (Myelodysplastic Syndrome) | Phase 2 / Phase 3 | Not yet recruiting | The Affiliated People's Hospital of Ningbo University | 10 | 2028-09-01 | 2026-11-12 |
| Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease KL003 Cell Injection - Sickle Cell Disease | Not applicable | Suspended | Institute of Hematology & Blood Diseases Hospital, China | 3 | 2028-03-01 | 2026-11-05 |
| OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren Monthly DP, Quarterly DP - Malaria, Asymptomatic Malaria | Phase 3 | Not yet recruiting | Indiana University | 1500 | 2028-01-01 | 2026-09-01 |
| Methadone as an Alternative Treatment for Children Underdoing HSCT PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia | Phase 3 | Suspended | University of Texas Southwestern Medical Center | 60 | 2028-01-01 | 2025-10-23 |
| Prenatal Transplantation for Fetuses With Fanconi Anemia IUHSCT for FA-affected fetuses - Fanconi Anemia, Anemia, Hypoplastic, Congenital | Phase 1 / Phase 2 | Not yet recruiting | Agnieszka Czechowicz | 12 | 2028-01-01 | 2026-06-16 |
| Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 12 | 2027-11-01 | 2026-04-13 |
| Self-administered Acupressure in Patients With Sickle Cell Disease Verum Acupressure (using AcuWand), Sham Acupressure (using AcuWand) - Sickle Cell Disease (SCD) | Not applicable | Not yet recruiting | University of Cincinnati | 300 | 2027-10-01 | 2026-10-15 |
| Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session - Sickle Cell Disease, Sickle Cell Anemia in Children | Not applicable | Not yet recruiting | Connecticut Children's Medical Center | 30 | 2027-09-01 | 2026-04-29 |
| Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin®) - Aplastic Anaemia | Phase 2 | Not yet recruiting | Anhui Provincial Hospital | 59 | 2027-08-01 | 2026-10-21 |
| Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/ βC Genotype Exa-cel - Sickle Cell Disease | Phase 3 | Withdrawn | Vertex Pharmaceuticals Incorporated | 2027-07-31 | 2026-03-25 | |
| Data Collection For Patients With Sickle Cell Disease data collection - Data Collection, Sickle Cell Disease | Not yet recruiting | M.D. Anderson Cancer Center | 500 | 2027-04-06 | 2026-11-03 | |
| A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS) Roxadustat, Placebo - Myelodysplastic Syndromes | Phase 3 | Not yet recruiting | Kyntra Bio | 201 | 2027-04-01 | 2026-07-23 |
| A Trial Evaluating Two Imetelstat Doses in Participants With Lower Risk Myelodysplastic Syndrome (MDS) Imetelstat (7.1 mg/kg), Imetelstat (3.55 mg/kg) - MDS (Myelodysplastic Syndrome), MDS | Phase 4 | Not yet recruiting | Geron Corporation | 100 | 2027-03-01 | 2026-11-16 |
| MBI for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease Mindfulness-based intervention - Chronic Pain, Sickle Cell Disease | Not applicable | Not yet recruiting | University of Illinois at Chicago | 48 | 2027-02-01 | 2026-09-21 |
| A Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients. FXS6837 Capsule - Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | Not yet recruiting | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 20 | 2027-01-26 | 2026-11-04 |
| Focused Ultrasound Neuromodulation for Chronic Pain Focused PCM-Guided CMN LIFU, Unfocused Control LIFU - Chronic Pain, Sickle Cell Disease | Not applicable | Not yet recruiting | University of Minnesota | 80 | 2027-01-04 | 2026-11-02 |
| Mechanisms Within the Autonomic Nervous SysTEm undeRlying MusIc Therapy's aNalgesic Effects in Sickle Cell Disease (MASTERMIND) Music Therapy - Sickle Cell Disease | Not applicable | Not yet recruiting | University Hospitals Cleveland Medical Center | 10 | 2027-01-02 | 2026-11-10 |
| Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris NM8074, Soliris - Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 12 | 2027-01-01 | 2026-04-13 |
| Buprenorphine for the Management of Pain in Children With Sickle Cell Disease Buprenorphine Buccal Film [Belbuca] - Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis | Phase 1 | Not yet recruiting | Natasha Archer | 25 | 2027-01-01 | 2026-11-04 |
| Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants Cord Blood Red Blood Cells, Standard Adult Donor Red Blood Cells - Extremely Premature Infant, Anemia Neonatal | Not applicable | Not yet recruiting | Hospital Clinic of Barcelona | 280 | 2027-01-01 | 2026-11-09 |
Showing 20 of 4692. Sign in to see all of them.
Anemia, Sickle Cell (1124) · Anemia, Iron-Deficiency (584) · Anemia, Aplastic (357) · Myelodysplastic Syndromes (344) · Anemia, Refractory, with Excess of Blasts (320) · beta-Thalassemia (264) · Leukemia, Myeloid, Acute (250) · Renal Insufficiency, Chronic (222) · Thalassemia (221) · Leukemia (220) · Hemoglobinuria, Paroxysmal (190) · Iron Deficiencies (187) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (178) · Leukemia, Myelomonocytic, Chronic (150)
Hemic and Lymphatic Diseases (4689) · Hematologic Diseases (4556) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1850) · Anemia, Hemolytic (1841) · Genetic Diseases, Inborn (1648) · Anemia, Hemolytic, Congenital (1530) · Hemoglobinopathies (1419) · Pathological Conditions, Signs and Symptoms (1183) · Nutritional and Metabolic Diseases (1055) · Bone Marrow Diseases (1035) · Metabolic Diseases (984) · Pathologic Processes (964) · Iron Metabolism Disorders (732) · Disease Attributes (664)
Cyclophosphamide (178) · Epoetin Alfa (166) · fludarabine phosphate (130) · Darbepoetin alfa (118) · ferric carboxymaltose (116) · Cyclosporine (115) · fludarabine (112) · Antilymphocyte Serum (101) · ferrous sulfate (101) · Whole-Body Irradiation (97) · Busulfan (94) · Hydroxyurea (90) · Mycophenolic Acid (90) · Iron (88) · continuous erythropoietin receptor activator (68)
National Heart, Lung, and Blood Institute (NHLBI) (124) · Hoffmann-La Roche (105) · Novartis Pharmaceuticals (83) · Assistance Publique - Hôpitaux de Paris (78) · Amgen (65) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (60) · St. Jude Children's Research Hospital (55) · Assiut University (50) · Institute of Hematology & Blood Diseases Hospital, China (50) · Alexion Pharmaceuticals, Inc. (48) · Fred Hutchinson Cancer Center (42) · Children's Hospital Medical Center, Cincinnati (41) · National Cancer Institute (NCI) (41) · Swiss Federal Institute of Technology (41) · GlaxoSmithKline (37)
United States (1923) · France (388) · China (353) · United Kingdom (331) · Italy (304) · Germany (267) · Canada (243) · Spain (195) · Egypt (139) · Netherlands (126) · Turkey (Türkiye) (125) · Belgium (122) · Australia (116) · Brazil (111) · South Korea (111)
John F Tisdale, M.D. (16) · Ariel Koren, MD (13) · Swee Lay Thein, M.D. (12)
PMID 36005278, PMID 36791280, PMID 41114449, PMID 34932836, PMID 26965694, PMID 37975597, PMID 33783815, PMID 36240296, PMID 38780066, PMID 34724566, PMID 37254256, PMID 29958797, PMID 38775255, PMID 29674506, PMID 40277027, PMID 40569673, PMID 41026975, PMID 42133908, PMID 23343061, PMID 23343062, PMID 23738544, PMID 26589907, PMID 29419434, PMID 31413088, PMID 34175041, PMID 34219224, PMID 36749544, PMID 38363466, PMID 40359056, PMID 40576086, PMID 18328118, PMID 19208097, PMID 20175775, PMID 21982521, PMID 24916507, PMID 26504182, PMID 30504345, PMID 30957581, PMID 31203241, PMID 31974203, PMID 32499241, PMID 32678434, PMID 33661274, PMID 34362786, PMID 34710946, PMID 34922648, PMID 36594181, PMID 36860093, PMID 36975201, PMID 37651553
2017 (24), 2023 (24), 2019 (23), 2016 (21), P30CA015704 (21), 2014 (17), 2015 (12), P30CA006973 (12), 2018 (11), 2005 (9), 2008 (9), 2009 (8), P30CA043703 (8), U01HL065238 (8), U54HL070587 (8)